Actavia Life Sciences, Inc.
RASP
Rank in Stocks
#33521
Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing... Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.
Share Price
$0.0005
Last synced: 2026-11-13
Market Cap
$385.91K
Change (1 day)
0.00%
Change (1 year)
-87.50%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Actavia Life Sciences, Inc. (RASP)
Category
Healthcare
Operating Margin for Actavia Life Sciences, Inc. (RASP)
Operating Margin as of November 2026 TTM: 0.00%
According to Actavia Life Sciences, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2023 the company had an operating margin of 0.00%.
Operating Margin history for Actavia Life Sciences, Inc. from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | -100.00% |
| 2014 | 11,438.57% | 0.00% |
| 2013 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| -195.39% | - |
US
|
|
| 33.87% | - |
US
|
|
| -116.04% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Actavia Life Sciences, Inc.'s operating margin
What was Actavia Life Sciences, Inc.'s operating margin in 2023?
In 2023, Actavia Life Sciences, Inc.'s operating margin was 0.00%, compared with 0.00% in 2022.
How has Actavia Life Sciences, Inc.'s operating margin changed since 2018?
From 2018 to 2023, Actavia Life Sciences, Inc.'s operating margin was highest in 2023 (0.00%) and lowest in 2023 (0.00%).
How does Actavia Life Sciences, Inc.'s operating margin compare with similar companies?
Actavia Life Sciences, Inc.'s operating margin (0.00%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.